Aripiborg, containing Aripiprazole 15 mg, is a medication prescribed for the management of schizophrenia and bipolar disorder. This article aims to provide a detailed overview of Aripiborg, covering its indications, dosage, administration, and other essential information.
Indications for Aripiborg Usage
Schizophrenia Treatment
Aripiborg 15 mg tablet is primarily indicated for the treatment of schizophrenia in adults and adolescents aged 15 years and older. Schizophrenia is a chronic mental disorder characterized by disturbances in thought, perception, and behavior. Aripiborg helps alleviate symptoms associated with schizophrenia and improves patients’ quality of life.
Bipolar I Disorder Management
In addition to schizophrenia, Aripiborg 15 mg tablet is also indicated for managing moderate to severe manic episodes in Bipolar I Disorder. It is effective as both monotherapy and combination therapy. Moreover, Aripiborg aids in preventing new manic episodes in patients who have responded to aripiprazole treatment previously.
Dosage and Administration Guidelines
For Adults
Schizophrenia:
- Starting Dose: The recommended starting dose for Aripiborg tablets is 10 or 15 mg/day.
- Maintenance Dose: A maintenance dose of 15 mg/day is administered on a once-a-day schedule.
- Dose Range: Aripiborg tablets are effective in a dose range of 10 to 30 mg/day.
Manic Episodes:
- Starting Dose: The recommended starting dose for Aripiborg tablets is 15 mg/day.
- Maintenance Dose: A once-a-day schedule without regard to meals is recommended.
- Maximum Daily Dose: The maximum daily dose should not exceed 30 mg.
For Pediatric Population (Adolescents 15 Years and Older)
Schizophrenia:
- Recommended Dose: The recommended dose for Aripiprazole tablets is 10 mg/day.
- Titration: Treatment initiation involves starting at 2 mg for 2 days, titrated to 5 mg for an additional 2 days, then reaching the recommended daily dose of 10 mg.
- Dose Range: Aripiborg tablets are effective in a dose range of 10 to 30 mg/day.
Package and Storage Information
- Packaging: Aripiborg tablets are supplied in a carton box containing a blister (PVC/Alu) of 10 tablets.
- Storage: It is recommended to store Aripiborg in a cool and dry place at a temperature not exceeding 30°C.
- Safety: Keep out of the reach of children and use under physician supervision.
Conclusion
Aripiborg, with its active ingredient Aripiprazole 15 mg, is a valuable medication for the management of schizophrenia and bipolar disorder. By adhering to the recommended dosage and administration guidelines, patients can effectively control their symptoms and improve their overall well-being.

FAQs
- Can Aripiborg be used in children below 15 years of age? Aripiborg is not recommended for use in patients below 15 years of age due to insufficient data on safety and efficacy.
- What are the maximum daily doses for adults using Aripiborg? The maximum daily dose for adults using Aripiborg is 30 mg, regardless of the indication.
- Are there any special considerations for titrating Aripiborg dosage in adolescents? Yes, adolescents should start with a lower dose and titrate gradually to minimize the risk of adverse effects.
- Is Aripiborg safe for long-term use in managing bipolar disorder? Aripiborg can be used for long-term management of bipolar disorder under the supervision of a healthcare professional.
- What should I do if I miss a dose of Aripiborg? If you miss a dose of Aripiborg, take it as soon as you remember. However, if it’s almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
Aripiborg 15 mg tablet: A Trusted Product by BORG PHARMACEUTICAL INDUSTRIES
Aripiborg 15 mg tablet is proudly manufactured by BORG PHARMACEUTICAL INDUSTRIES, an Egyptian shareholding company, was established in 2001 for manufacturing pharmaceuticals, cosmetics, and dietary supplements. Founded by Egyptian pharmacists, health professionals, and businessmen, it started production in July 2004. The company’s capital increased over the years, reaching 100 million L.E. in 2017. It obtained various ISO certifications for its management system. Authorized manufacturing activities include solid, liquid, and semi-solid dosage forms.
To obtain further information, please reach out to Borg Pharmaceutical Industries. Borg Pharmaceutical Industries has multiple locations in Egypt:
- Factory Address: District 17, Areas 1, 3, Industrial Zones 3, Borg El Arab New City, Alexandria. Tel: (+203) 4622151/2/3/4, (+2) 012/27872244 Fax: (203) 4622155
- Alexandria Scientific Office: Address: Alex Agricultural Road, Pharma City Smouha, Pancee Building, 2nd Floor, Alexandria. Tel: (+2) 012/27865773, (+2) 012/81367423
- Cairo Branch: Address: Refaat Hassan Street, Area 7/4/1 First Floor, Apartment No. “1”, Beside Diar City Compound, El Haddaba El Wossta, Second District, Mokattam, Cairo. Tel: (+202) 27303131, (+2) 27303132, (+2) 27303133 Fax: (+202) 27303130
- Mansoura Branch: Address: 14, Ali Ibn Abi Taleb Street, Samia EL Gaml Division, branched from Ahmed Maher St. Tel: (+2050) 2225847 Fax: (+2050) 2225847
- Upper Egypt Souhag Branch: Address: 136, Eltahrir Street, Beside Police Station. Tel: (+2093) 2109300
Dr. Ahmad Baker, PharmD
Senior Pharmacist & Health Educator
With over 23 years of clinical experience in hospital and community pharmacy across Egypt and Saudi Arabia, Dr. Ahmad specializes in reproductive health and pharmaceutical safety. He is dedicated to providing evidence-based guidance to empower patients in the MENA region.
Medical Disclaimer: This content is for educational purposes and reflects the latest pharmaceutical protocols. It is not a substitute for personal medical advice. Always consult Dr. Ahmad Baker or your healthcare provider before starting any treatment.

